News - Pharmaphorum

Latest News

in News News
Cardiologist Maulik Majmudar joins Amazon’s health revolution
August 21, 2018 Share
X
Cardiologist Maulik Majmudar joins Amazon’s health revolution
https://pharmaphorum.com/news/cardiologist-maulik-majmudar-joins-amazons-health-revolution/
in News News News
AstraZeneca gets further approval for Tagrisso in Japan
August 21, 2018 Share
X
AstraZeneca gets further approval for Tagrisso in Japan
https://pharmaphorum.com/news/astrazeneca-tagrisso-approval/
in News News
NHS lifted Imbruvica restrictions after press campaign
August 21, 2018 Share
X
NHS lifted Imbruvica restrictions after press campaign
https://pharmaphorum.com/news/nhs-lifted-imbruvica-restrictions/
in News
Warning over NHS drug supply as no-deal Brexit looms
August 21, 2018 Share
X
Warning over NHS drug supply as no-deal Brexit looms
https://pharmaphorum.com/news/warning-over-nhs-drug-supply-as-no-deal-brexit-looms/

NHS lifted Imbruvica restrictions after press campaign

England’s National Health Service has lifted restrictions on Janssen’s blood cancer drug Imbruvica (ibrutinib), after a journalist who

NHS lifted Imbruvica restrictions after press campaign

https://pharmaphorum.com/news/nhs-lifted-imbruvica-restrictions/

Warning over NHS drug supply as no-deal Brexit looms

NHS Providers calls for national contingency plan

Warning over NHS drug supply as no-deal Brexit looms

https://pharmaphorum.com/news/warning-over-nhs-drug-supply-as-no-deal-brexit-looms/

Opdivo and Keytruda approved in new lung cancer uses

The FDA has approved Merck’s Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer

Opdivo and Keytruda approved in new lung cancer uses

https://pharmaphorum.com/news/bmss-opdivo-approved-lung-cancer/

See all

This week’s news

Roche’s Alecensa fast-tracked in China

China’s national regulator has granted a rapid approval for Roche’s lung cancer treatment Alecensa just months after European

Roche’s Alecensa fast-tracked in China

https://pharmaphorum.com/news/roches-alecensa-fast-tracked-china/

Merck launches map4health diabetes mobile app

App is result of 11-year collaboration with Healthy Interactions

Merck launches map4health diabetes mobile app

https://pharmaphorum.com/news/merck-launches-map4health-diabetes-mobile-app/

Novo’s oral semaglutide on target in phase 3 trial

Novo Nordisk continues to build a case for its oral semaglutide GLP-1 class diabetes drug, with latest results

Novo’s oral semaglutide on target in phase 3 trial

https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/

Vertex’s Orkambi CF drug okayed for funding in Australia

Committee recommends outcomes-based deal

Vertex’s Orkambi CF drug okayed for funding in Australia

https://pharmaphorum.com/news/vertexs-orkambi-cf-drug-okayed-for-funding-in-australia/

AstraZeneca to present the latest cardiovascular research

AstraZeneca and MedImmune will present new data from its Cardiovascular, Renal and Metabolism (CVRM) portfolio for the treatment

AstraZeneca to present the latest cardiovascular research

https://pharmaphorum.com/news/astrazeneca-presents-latest-cardio-research/

NICE rejects Perjeta in post-surgery breast cancer use – again

NICE has continued to reject Roche’s Perjeta (pertuzumab) in its use to prevent early-stage HER2-positive breast cancer from

NICE rejects Perjeta in post-surgery breast cancer use – again

https://pharmaphorum.com/news/nice-rejects-perjeta-in-post-surgery-breast-cancer-use-again/

Novo acquires UK biotech Ziylo to develop “smart” insulin

Danish pharma hopes Ziylo’s tech will lead to glucose responsive insulin

Novo acquires UK biotech Ziylo to develop “smart” insulin

https://pharmaphorum.com/news/novo-acquires-ziylo-smart-insulin/

Hackers could take control of medical devices, McAfee warns

Research published by cyber security company, McAfee, shows it is possible to modify real-time patient heart monitor data

Hackers could take control of medical devices, McAfee warns

https://pharmaphorum.com/news/mcafee-hacks-vital-medical-equipment/

HIV drug cuts viral load, boosts immunity in Yale study

A Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in

HIV drug cuts viral load, boosts immunity in Yale study

https://pharmaphorum.com/news/ibalizumab-cuts-hiv-viral-load/

Regeneron/Teva pain drug fasinumab on target in phase 3

Pfizer and Eli Lilly are competitors in NGF research

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

US regulators expand label for Vertex’s Kalydeco CF drug

New label includes children aged 12-24 months

US regulators expand label for Vertex’s Kalydeco CF drug

https://pharmaphorum.com/news/us-regulators-expand-label-for-vertexs-kalydeco-cf-drug/

Robot-powered digital pharmacy to open in Liverpool

A robot-powered digital pharmacy is to open in Liverpool, aimed at helping people with chronic conditions get medicines

Robot-powered digital pharmacy to open in Liverpool

https://pharmaphorum.com/news/robot-powered-digital-pharmacy-opens/

Pfizer invests in mRNA vaccine powerhouse BioNTech

Pfizer is to pay German company BioNTech up to $425m for a multi-year collaboration in the development of

Pfizer invests in mRNA vaccine powerhouse BioNTech

https://pharmaphorum.com/news/pfizer-invests-mrna-vaccine-biontech/

Steve Paul reignites xanomeline research as Karuna CEO

Karuna aims to overcome safety concerns with combination therapy

Steve Paul reignites xanomeline research as Karuna CEO

https://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/

Cancer Research UK gives $4m funding to Glasgow Uni CML project

Cancer Research UK granted £3.1m (nearly $4m) to a group of researchers at the University of Glasgow to

Cancer Research UK gives $4m funding to Glasgow Uni CML project

https://pharmaphorum.com/news/experimental-leukaemia-study-grant/

Partner content

Press releases

Event Highlights for 13th Annual Industry Leading Cold Chain Distribution 2018

https://pharmaphorum.com/partner-content/event-highlights-for-13th-annual-industry-leading-cold-chain-distribution-2018/

Insightful Developments and an Exclusive Interview from Roche

https://pharmaphorum.com/partner-content/insightful-developments-and-an-exclusive-interview-from-roche/

Invitation from Chair of this year’s Immuno-Oncology Conference in London

https://pharmaphorum.com/partner-content/invitation-from-chair-of-this-years-immuno-oncology-conference-in-london/

Your Exclusive Invitation from the Chair for Cell & Gene Therapy 2018

https://pharmaphorum.com/partner-content/your-exclusive-invitation-from-the-chair-for-cell-gene-therapy-2018/

See all

Appointments

Medmeme appoints senior strategist for Europe

https://pharmaphorum.com/partner-content/medmeme-appoints-senior-strategist-for-europe/

Betsy Bondurant joins 3Sixty Event Consulting to lead US operations

https://pharmaphorum.com/partner-content/appointments/betsy-bondurant-joins-3sixty-event-consulting-to-lead-us-operations/

See all

Search

Advanced Search

Trending

Latest News

This week’s news

Press releases

Appointments